What is the recommended diagnostic work‑up for autoimmune orchitis in a man presenting with painless or mildly painful testicular enlargement, gradual loss of testicular volume, or infertility after infectious, traumatic, neoplastic, and hormonal causes have been excluded?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Work-Up for Autoimmune Orchitis

When infectious, traumatic, neoplastic, and hormonal causes have been excluded in a man presenting with painless or mildly painful testicular enlargement, gradual testicular volume loss, or infertility, the diagnostic work-up for autoimmune orchitis should prioritize detection of anti-sperm antibodies (ASA) and testicular biopsy to identify characteristic lymphocytic infiltration patterns.

Clinical Presentation and Classification

Autoimmune orchitis presents in two distinct forms that require different diagnostic approaches:

Primary Autoimmune Orchitis

  • Primary autoimmune orchitis is typically asymptomatic and presents with isolated infertility without systemic disease, characterized by ASA in 100% of cases directed against the basement membrane or seminiferous tubules. 1
  • The condition manifests as gradual, painless testicular volume loss rather than acute inflammation, making it difficult to diagnose during the active inflammatory stage. 2
  • Testicular atrophy develops progressively as the chronic inflammatory process damages the seminiferous epithelium irreversibly. 2

Secondary Autoimmune Orchitis

  • Secondary autoimmune orchitis presents with symptomatic orchitis and/or testicular vasculitis associated with systemic autoimmune diseases, particularly vasculitis syndromes. 1
  • Patients typically demonstrate testicular pain, erythema, and/or swelling, distinguishing it from the primary form. 1
  • ASA are detected in up to 50% of secondary cases, especially in systemic lupus erythematosus patients. 1

Essential Diagnostic Tests

Anti-Sperm Antibody Testing

  • Serum ASA testing is the cornerstone non-invasive diagnostic test for autoimmune orchitis, with ASA present in approximately 5-12% of infertile male partners. 3
  • ASA cause immobilization and/or agglutination of spermatozoa, blocking sperm-egg interaction and resulting in infertility. 1
  • The presence of ASA directed to the basement membrane or seminiferous tubules confirms the autoimmune nature of the orchitis. 1

Testicular Biopsy

  • Testicular biopsy is required for definitive diagnosis when non-invasive techniques fail to establish the etiology, as systematic histopathological analyses show a high prevalence of asymptomatic inflammatory reactions in infertile men. 4
  • The characteristic histological finding is lymphocytic infiltration surrounding the tubuli recti, which then induces spermatogenic disturbance. 2
  • Focal lymphocytic infiltrates correlate with the degree of damage to spermatogenesis and corresponding clinical and endocrinological parameters of testicular function. 4
  • Biopsy should be performed when testicular volume is <12 mL with elevated FSH, as this combination warrants exclusion of intratubular germ cell neoplasia in addition to inflammatory processes. 5

Scrotal Ultrasound with Doppler

  • Scrotal ultrasound with Doppler is indicated to quantify testicular volume, assess architecture, and rule out masses, with volumes <12 mL considered definitively atrophic. 5
  • Ultrasound can identify reactive hydrocele and increased peritesticular blood flow that may accompany inflammatory processes. 6
  • High-frequency probes (>10 MHz) should be used to maximize resolution and accurate caliper placement for precise volume assessment. 5

Hormonal Evaluation

  • Morning serum FSH, LH, and total testosterone should be drawn between 08:00–10:00 h on at least two separate occasions to obtain reliable baseline values. 5
  • Elevated FSH (>7.6 IU/L) in the context of testicular atrophy indicates reduced testicular reserve and impaired spermatogenic capacity. 5, 7
  • The LH pattern helps distinguish primary testicular dysfunction (elevated LH) from secondary causes (low or normal LH). 5

Semen Analysis

  • At least two semen analyses separated by 2-3 months should be performed, as single analyses can be misleading due to natural variability. 5
  • Semen analysis evaluates concentration, motility, morphology, and total count, which collectively reflect testicular function better than any single parameter. 8
  • The presence of increased round cells in semen may indicate spermatogenic problems with spermatocytes and/or round spermatids present in the ejaculate. 7

Diagnostic Algorithm

  1. Confirm exclusion of other causes:

    • Rule out infectious orchitis with appropriate cultures and serologies
    • Exclude testicular neoplasm with tumor markers (AFP, β-hCG, LDH) and scrotal ultrasound 6
    • Verify normal hormonal function or identify specific patterns of dysfunction 5
  2. Perform initial non-invasive testing:

    • Obtain serum ASA testing as the primary screening test 3, 1
    • Conduct scrotal ultrasound with Doppler to assess testicular volume and architecture 5
    • Measure morning FSH, LH, and testosterone on two separate occasions 5
    • Obtain two semen analyses separated by 2-3 months 5
  3. Proceed to testicular biopsy if:

    • ASA are positive with unexplained infertility and testicular atrophy 1
    • Testicular volume is <12 mL with elevated FSH (>7.6 IU/L) 5
    • Non-invasive testing is inconclusive but clinical suspicion remains high 4
    • Multiple biopsies should be performed to exclude intratubular germ cell neoplasia when volume is <12 mL 5

Critical Diagnostic Pitfalls

  • Chronic asymptomatic inflammations of the testicles are underestimated as a primary cause or cofactor of male fertility disorders because non-invasive diagnostic techniques are not yet widely available. 4
  • The majority of patients with testicular autoimmunity have chronic and asymptomatic development of the inflammatory reaction, making diagnosis at the ongoing stage very difficult. 2
  • Histopathology of idiopathic spermatogenic disturbance in the clinic may represent the post-active inflammation stage of autoimmune orchitis, when irreversible damage has already occurred. 2
  • Testicular biopsy should be considered for infertile men with atrophic testes (<12 mL) and testicular microcalcification, as this combination increases the risk of testicular germ cell tumors. 8

Management Considerations After Diagnosis

  • Glucocorticoids and immunosuppressive drugs are indicated in autoimmune orchitis associated with active systemic autoimmune diseases, though there are no standardized treatment options. 3
  • Assisted reproductive technologies (intrauterine insemination, in vitro fertilization, and intracytoplasmic sperm injection) are therapeutic options for male infertility associated with ASA. 3
  • ICSI is considered the best choice for patients with severe sperm autoimmunity, particularly in males with low semen counts or motility. 3
  • Sperm cryopreservation should be performed immediately if any sperm are present in ejaculate, banking 2-3 separate collections to provide insurance against progressive decline. 5

References

Research

Cutting-edge issues in autoimmune orchitis.

Clinical reviews in allergy & immunology, 2012

Research

[Orchitis and male infertility].

Der Urologe. Ausg. A, 2010

Guideline

Testicular Size and Volume Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Sperm Production in Atrophied Testicles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Would orchitis (inflammation of the testis) be visible on an ultrasound in a patient with sudden testicular atrophy, low testosterone levels, and elevated Follicle-Stimulating Hormone (FSH) levels, but no apparent inflammation?
What is the initial management for a 17-year-old male with orchitis?
I'm a male of reproductive age with a history of sudden erectile dysfunction, low libido, and yellow semen that resolved, but now I've noticed a decrease in testicular size over the last 6 months, could I have had orchitis or mumps, what's causing my testicular atrophy?
Can an asymptomatic Sexually Transmitted Disease (STD) cause testicular atrophy?
What is the treatment for orchitis (inflammation of the testes)?
What are the dosing guidelines, safety precautions, contraindications, monitoring requirements, drug interactions, and alternative therapies for sodium valproate in adults and children?
In a 36‑year‑old woman with persistent sore throat and dysphagia after an incomplete 10‑day course of amoxicillin and a completed 5‑day azithromycin course, who now has a positive rapid antigen detection test for group A Streptococcus and is taking verapamil for postural orthostatic tachycardia syndrome, what is the most appropriate next step in management?
What is the appropriate hydrochlorothiazide dosing and monitoring plan for a 70‑year‑old hypertensive patient?
What are the common causes of right axis deviation on a standard 12‑lead electrocardiogram?
How should oral opioid analgesics be initiated, titrated, and monitored in an opioid‑naïve adult with pain?
Should a healthy 42-year-old man with genital warts be vaccinated with the human papillomavirus (HPV) vaccine (Gardasil 9)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.